⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AKTX News
Akari Therapeutics plc ADR (0.01 USD)
Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board
globenewswire.com
AKTX
Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board
globenewswire.com
AKTX
Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
globenewswire.com
AKTX
Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline
globenewswire.com
AKTX
JTC Team Companies to Present in Webull Corporate Connect Webinar Series Happening February 10-11, 2026
accessnewswire.com
AKTX
DCOY
GRI
MBRX
AIM
BULL
Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
globenewswire.com
AKTX
Akari Therapeutics Files Key Patent and Unveils Second ADC Program AKTX-102 Targeting CEACAM5 Expressing Solid Tumors
globenewswire.com
AKTX
ReAlta Life Sciences Announces Appointment of Kia Motesharei, Ph.D. to Board of Directors
businesswire.com
MDGL
AKTX
Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026
globenewswire.com
AKTX
Akari Therapeutics to Present at the 2026 Biotech Showcase
globenewswire.com
AKTX